Endo International PLC (Over The Counter Market:ENDPQ)

Delayed Data
As of Nov 30
 +0.0003 / +13.64%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment's operations are currently conducted through Paladin's leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

Contact Information

Endo International Plc
Minerva House
Dublin Dublin 4
P:(531) 268-2000
Investor Relations:
(845) 364-4833



Individual stakeholders2.29%
Mutual fund holders0.71%
Other institutional0.00%

Top Executives

Blaise A ColemanPresident, Chief Executive Officer & Director
Robert PolkeExecutive VP & Global Head-Operations
Mark BradleyChief Financial Officer & Executive Vice President
James Patrick TursiExecutive VP-Global Research & Development
Cheryl StouchChief Information Officer